Publications by authors named "Mark Zenker"

Claim this Profile
L
Long-Term Favorable Cardiac Remodeling in Obstructive Hypertrophic Cardiomyopathy Patients Treated With Mavacamten for Up to 128 Weeks: Insights From the VALOR-HCM Trial.
Milind Y Desai, Yuichiro Okushi, Kathy Wolski, Jeffrey B Geske, Anjali Tiku Owens, Mark A Zenker

JACC Cardiovasc Imaging· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study.
Olives Nguyen, Jack Wiedrick, Daniele Massera, Elizabeth Adlestein, Sumar Frejat, Mark A Zenker

medRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Response of Obstructive Hypertrophic Cardiomyopathy Patients to Mavacamten Based on Sex: Insights From the VALOR-HCM Trial.
Milind Y Desai, Sara Saberi, Jeffrey B Geske, Andrew Wang, Paul Cremer, Mark A Zenker

JACC Heart Fail· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effects of Mavacamten on Patients Based on Hypertrophic Cardiomyopathy Pathogenic Genetic Variant Status: Insights From VALOR-HCM Trial.
Milind Y Desai, Anjali Owens, Sara Saberi, Andrew Wang, Kathy Wolski, Mark Zenker

Circ Genom Precis Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myocarditis: Diagnostic Modalities and Treatment Options.
Dihan Thilakaratne, Roshan Bista, Mark Zenker, Rohan Kaza, Sasan Raissi

Cureus· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis